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Through billions of years of evolution nature has created and
refined structural proteins for a wide variety of specific
purposes. Amino acid sequences and their associated folding
patterns combine to create elastic, rigid or tough materials. In
many respects, nature’s intricately designed products provide
challenging examples for materials scientists, but translation of
natural structural concepts into bio-inspired materials requires
a level of control of macromolecular architecture far higher than
that afforded by conventional polymerization processes. An
increasingly important approach to this problem has been to use
biological systems for production of materials. Through protein
engineering, artificial genes can be developed that encode
protein-based materials with desired features. Structural ele-
ments found in nature, such as b-sheets and a-helices, can be
combined with great flexibility, and can be outfitted with
functional elements such as cell binding sites or enzymatic
domains. The possibility of incorporating non-natural amino
acids increases the versatility of protein engineering still
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further. It is expected that such methods will have large impact
in the field of materials science, and especially in biomedical
materials science, in the future.
Introduction
For many years materials scientists have been investigating the
possibilities of obtaining higher levels of control in polymer
synthesis. Although important progress has been made, espe-
cially in recent years with the advance of controlled radical
polymerization techniques,1 the level of control characteristic of
biomacromolecules, such as DNA and proteins, remains
unsurpassed.
In the nomenclature of polymer chemistry, organisms prepare
monodisperse polymers with predetermined chain lengths. But
more important is the fact that virtually complete control is
achieved over the sequence of the monomeric units, the amino
acids. The information stored in the primary sequence results in
a three-dimensional folded structure for each protein, which is
largely responsible for the most important protein properties.
For every specific function, nature has refined protein structures
through eons of evolution. It is striking that with the same set of
amino acid building blocks such diverse products can be
prepared, including globular proteins which function as en-
zymes as well as fibrous proteins with structural properties,
such as collagen. It is the prospect of creating three-dimensional
ordered structures by designing the requisite amino acid
sequences that motivates much of the current interest in protein-
based materials.2
Materials scientists have much to learn from the organiza-
tional principles employed in nature, and substantial progress
has been made recently in elucidation of the three-dimensional
architectures of fibrous proteins such as silks, elastins, and
collagens. An important challenge, however, is to translate
these concepts into synthetic or bio-inspired materials, which
would lead to new kinds of high performance materials.3
Because of the importance of control at the monomer level, the
most promising approach to this target is to use the biosynthetic
pathways of (micro)-organisms to synthesize macromolecular
materials.
Protein engineering has been used for the design and
modification of globular proteins for many years, and standard
biological tools have been developed that can now be used to
prepare structural proteins.4 It is remarkable that only in the past
decade, and especially in the last 5 years, has this approach to
materials design become a serious topic of investigation.
This review is not meant to be comprehensive, but instead
will present examples of some of the latest developments in the
field of protein engineering directed toward the preparation of
high performance materials. After a short explanation of the
protein engineering technique, examples will be given of
structural proteins found in nature and attempts to use these
basic structures for the preparation of new protein-based
materials. We will conclude with new methods that allow the
scope of protein engineering to be extended to building blocks
other than the natural amino acids, developments that promise
to make this technique even more versatile in the hands of the
materials chemist.
Protein engineering
Scheme 1 shows the overall process of materials synthesis via
protein engineering.5 Often—though not always—based on
natural structures, amino acid sequences are chosen to create
specific folding patterns and desired material properties. The
primary amino acid sequence can then be reverse-translated into
a corresponding nucleotide sequence. There are 2 methods of
obtaining the needed DNA fragments. One possibility is to
clone these sequences from an organism that produces the
desired structural protein. The second option is to synthesize
artificial genes by solid phase techniques. The second method of
course allows maximum freedom in designing the target
sequence. Because many structural proteins are characterized
by repetitive amino acid sequences, it is often possible to
multimerize a smaller oligonucleotide sequence to prepare an
artificial gene that codes for proteins of high molecular
weight.
This multimerization process can be considered as a
polycondensation, which therefore results in a set of genes with
different lengths. After construction of the artificial gene
library, each individual gene is incorporated into circular
plasmid DNA, which can be used to transform an appropriate
bacterial host. Most commonly the bacterial host E. coli is used
for these purposes. The plasmids are replicated during every
division of the bacterial cells. Because there is only one type of
plasmid per cell, screening of the plasmids of individual
bacterial colonies leads to isolation of specific artificial genes,
each encoding a protein-based material with a specific molec-
ular weight.
The selected artificial gene is first analyzed to verify its
sequence, and then cloned into a second plasmid which allows
protein expression. The expression plasmid contains a promoter
site for recognition by mRNA polymerase and a switch that
regulates protein production from the gene of interest.
The expression plasmid is re-introduced into the bacterial
host, and the host cells are allowed to grow to high cell density.
During this stage the plasmid switch is turned off in order to
prevent protein production from the artificial gene. Premature
protein synthesis can be detrimental to cell growth. After
sufficient cell density is reached the switch is turned on (a
process called induction) and expression of the desired protein
begins. Often the synthesis of other cellular proteins is slowed
dramatically after induction.
Spider dragline silk
Among the most thoroughly studied classes of structural
proteins is silk.6 There are many forms of silk, of which that
from Bombyx mori (Chinese silkworm silk)7,8 and dragline
spider silk of the Nephila clavipes (the golden orb weaver) have
drawn most attention.9 Silkworm silk of course is of interest
because it is produced in large quantities and used as textile
fiber. Spiders produce a large variety of types of silk, each one
meant for a specific purpose, such as web construction or
trapping of prey. Of all these different types of spider silk,
dragline spider silk of Nephila clavipes is regarded as nature’s
high performance fiber, with a remarkable combination of
strength and toughness. Values reported for its mechanical
properties are an E-modulus of 10–50 GPa, elongation to break
of 10–30% and tensile strength of 1.1–1.4 GPa. These values are
Scheme 1 Overview of the protein engineering methodology.
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dependent on moisture content and strain rate. The effect of
humidity is of utmost importance. Silk exposed to water can
shrink to less than half of its original length, and the
supercontracted fibers then show rubberlike behavior.9 Al-
though this is a desirable feature under natural conditions,
because it allows spider webs to reshape in the dewy evening, it
is less practical when one wants to apply this material as a high
performance fiber. The large variation in properties is a result of
the difficulty in maintaining constant conditions under which
spiders produce their silk. In recent years important insight has
been obtained into the three-dimensional structures of the
different types of silk. X-ray diffraction,10 state of the art NMR
techniques11,12 and IR and Raman spectroscopy13 have helped
to unravel the architectural reasons why this class of structural
proteins has its remarkable mechanical properties. Silks from
both silkworms and spiders contain repetitive sequences of
crystalline and amorphous domains (Fig. 1). The crystalline
domains are responsible for the strength of the material,
whereas the amorphous protein matrix: i) allows the crystalline
domains to orient under strain to increase the strength of the
material, and ii) introduces flexibility to increase the energy to
break.
The crystalline domains comprise highly repetitive amino
acid sequences consisting of alanine rich b-sheets. In Bombyx
mori silk the most important repeat sequence is (Ala Gly); for N.
clavipes dragline spider silk it is predominantly poly Ala.
In contrast to silkworm silk, there is no readily available
source for spider dragline silk, and protein engineering
techniques have been explored as a means of scaling up
production. Furthermore, changes in the silk structure might be
made to produce a material less sensitive to water. The
combination of bacterial production with a synthetic processing
step should allow better control of mechanical properties as
compared to natural silk. On the other hand, development of
methods of posttranslational silk spinning is not a straightfor-
ward process.
The first protein engineering attempts were made by using
large parts of the native spider silk genes. After incorporation of
these cDNA fragments into E. coli expression systems however,
difficulties arose from gene and protein stability, and truncated
proteins were produced. Clones larger than 2.5 kb proved to be
unstable.14,15 The same behavior was observed for native
silkworm silk genes. An explanation for this phenomenon may
lie in the highly repetitive nature of these sequences, which
renders the coding sequence susceptible to genetic recombina-
tion. Differences in codon preferences between the silkworm
and the bacterial host could also reduce expression effi-
ciency.16
The first attempts using synthetic genes based on the native
gene sequence were reported as early as 1990 by Cappello and
Ferrari,17 who used silkworm fibroin analogues. Better results
were obtained than when the cDNA genes were used, although
the levels of protein production remained relatively low,
especially for high molecular weight variants.18 The best results
reported thus far with E. coli expression systems were obtained
by Winkler et al. for spider dragline silk (25–40 mg L21 cell
culture)19 and Krejchi et al. for an (AG)3EG20 repetitive
material.21,22 To increase protein yield, high cell density
production was performed, and allowed preparation of multi-
gram quantities of product (25 g protein/35 L culture).23
Another approach to this problem has involved changes in the
production host. O’Brien et al. have shown that with the yeast
Pichia pastoris it was possible to produce spider silk-like
material in larger quantity (1 g L21).24 Even mammalian hosts
are now being investigated, such as Nexia’s transgenic goats,
which produce milk containing spider silk protein.25
Protein production in large quantity is just one of the
problems related to obtaining silk-like fibers. An equally
difficult aspect is spinning of the polypeptide, to create a
material with the correct three-dimensionally ordered structure.
Recently, using micro-spinneret techniques, Jelinski et al. have
succeeded in processing regenerated Bombyx mori silk fibers
that show similar properties when compared to their native
counterparts.26,27
Protein engineering can also play a role in improving
processing of silk like materials. Introduction of methionine
residues flanking the b-sheet domains creates a tool for
chemical control of structural organization.28 By oxidizing the
methionine units, b-sheet formation was prevented, which also
increased solubility, while sheet formation was restored after
reduction. Enzymatic techniques have also been developed to
induce this transition. The functional oligopeptide RGYSLG is
a recognition site for cyclic AMP-dependent kinase, which
phosphorylates the hydroxy function of the serine residue.19
Introduction of this recognition site into the structural protein
allowed Winkler et al. to prevent b-sheet formation upon
phosphorylation. Sheet formation was restored after dephos-
phorylation.
Recent insights into the mechanical properties of silk29 have
shown that it is not necessary or desirable to prepare purely b-
sheet sequences; a certain amount of disorder should also be
introduced to allow reorientation of the b-sheet crystalline
domains. With protein engineering this could be accomplished
by producing multiblock copolymers of b-sheet structures
flanked by random oligopeptides. Such block copolymers have
been reported by Conticello et al., who synthesized multiblock
copolymers consisting of alanine-rich blocks and elastin-
mimetic domains.30 This method leads to good protein yield (50
mg L21 culture) and a method for controlling b-sheet formation
by concentration from an aqueous solution.
With respect to silk-like polymers, protein engineering is
probably the only synthetic method that will allow high
molecular weight materials to be prepared in sufficient quantity
for materials applications. The ability to introduce switches for
b-sheet formation as well as the production of multiblock
copolymers will ultimately lead to materials with predictable
processing behavior and mechanical properties.
Mussel byssus thread
Another masterpiece of a structural material found in nature is
the mussel byssus thread. This thread is used to attach the
mussel to a surface, and must be tough enough to withstand
challenging marine conditions. Extensive investigations by
Fig. 1 Schematic representation of the organization of amorphous and
crystalline domains in silk fibers. Silk has inspired protein engineers to
construct b-sheet materials. A detail of a silk-like peptide sequence
((AG)3EG)n21,22 is encircled.
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Waite and coworkers have shown that the thread consists
predominantly of a gradient of two pentablock copolymers,
which are held together by so-called dovetail proteins, and
which provide a graded distribution of strength and structure
(Fig. 2).31–33
The polymer that is predominant at the proximal end of the
thread (i.e. closest to the mussel tissue) consists of a central
collagen block flanked by 2 elastic domains and 2 polyhistidine
sequences. The latter are expected to give rise to metal
complexation between the different peptide structures. The
elastin fragments introduce flexibility into the structure,
whereas the collagen part is responsible for stiffness. Further
down the byssus, and therefore closer to the substratum to which
the mussel is attached, the elastin fragments are replaced by
silk-like b-sheet domains. This structure therefore becomes
much more rigid. The entire byssus is built up by a mussel
within 5 minutes, and is about five times tougher and more
extensible than Achilles tendon. After processing the proteins
are also covalently connected. The complexity of a simple
mussel byssus thread is thus far greater than that characteristic
of materials produced by present-day synthetic polymer
processing techniques.
Although this material would be an ideal target for protein
engineering, no efforts toward this end have been reported. A
possible reason could be the high content of collagen in these
structures. Collagens are the most abundant family of structural
proteins in the human body, and are an important constituent of
ligaments, cartilage and bone. They are generally characterized
by the repetitive sequence GXY, in which X is often proline and
Y often hydroxyproline. Collagens form triple helices, which
provide critical building blocks for higher ordered aggregates.34
Because of their strong tendency to self-assemble, collagens
become insoluble very quickly. The few protein engineering
attempts reported thus far have failed for this (or perhaps other)
reasons.35 The need for a protein engineering approach for
collagen is also not as pressing as for spider silk, because
collagen is available in large quantities from mammalian
sources. On the other hand, the repetitive sequence of collagen
may be of value as an element in designed peptide-based
materials, as shown by the example of the mussel byssus
thread.
The mussel byssus contains more surprising peptides. The
tendons have to be attached to the substrate under aqueous
conditions. Nature therefore has developed a series of extraordi-
nary protein glues, which work even in saline media. Careful
analysis of these proteins, which must be done under conditions
where the protein hasn’t formed a network, shows that the
adhesive proteins are rich in proline, tyrosine and lysine.36
Furthermore, proline and tyrosine are posttranslationally trans-
formed into 4-hydroxyproline and L-3,4-dihydroxyphenylala-
nine (DOPA), respectively. The DOPA units are expected to
contribute to crosslinking via radical processes, in order to form
networks and assist in adhesion.37 Researchers intrigued by this
phenomenon have prepared synthetic genes and expressed the
corresponding (AKPSYPPTYK)n polypeptides.38 These model
peptides were treated with mushroom tyrosinase to convert the
tyrosine units into DOPA, and thereby to induce crosslinking.
Because expression yields were low, insufficient material was
produced for a thorough evaluation. Furthermore, the question
remains whether protein engineering is necessary in this case.
Deming et al. have used NCA polymerization techniques to
prepare copolypeptides consisting of lysine and DOPA residues
to investigate the adhesive potential of these structures.39 Based
on the positive results obtained from this research, one can
conclude that at least some of the key adhesive properties do not
require the specific protein sequence; only the presence of the
functional amino acids DOPA and hydroxyproline is essential.
For such materials it will be more convenient to pursue the
(improved) NCA polymerization routes than protein engineer-
ing.40 More subtle effects of sequence may become apparent
upon further analysis of the structure and properties of the
adhesive proteins.
Elastin
One of the most versatile materials, especially from a protein
engineering point of view is elastin. Elastin is a connective
tissue protein that provides a combination of strength and
flexibility in the extracellular matrix. Elastins are characterized
by simple repeating sequences, and in contrast to silks or
collagens, this family of materials does not suffer from
significant solubility problems. At low temperatures elastin-like
polypeptides are highly soluble in aqueous solutions and adopt
random coil conformations. Elastins, however, display lower
critical solution temperature (LCST) behavior, which means
that the proteins form ordered structures upon raising tem-
perature. The loss of entropy of the protein chain, when the
structure folds itself into a b-helix conformation, is compen-
sated by the release of water from the chain. A thoroughly
investigated series of elastin proteins is based on the pentapep-
tide sequence VPGVG.41–43 The structure and function of
elastins are maintained as long as the glycine and proline
residues are present, and the second valine residue can be
replaced by any other amino acid. This property provides a
means to control the temperature of the phase transition. When
a more hydrophobic unit, such as tryptophan, replaces valine,
the LCST drops significantly, and the transition temperature can
be raised by introduction of more polar moieties such as
glutamic acid. In the latter case, the phase transition is also made
pH dependent. The pioneering work of Urry has shown that
changing hydrophobicity leads to a broad spectrum of transition
temperatures. The phase transition can also be induced
electrochemically. For this purpose nicotinamide adenine
nucleotide (NAD) is attached to glutamic acid residues within
the peptide sequence. Reduction of NAD to NADH creates a
more hydrophobic domain and therefore a lower transition
temperature. Elastin materials have been made both by organic
chemical techniques, and by microbial protein expression.
Although it has been shown that one repeat unit of VPGVG is
sufficient to allow the transition from random coil into an
ordered b-helix structure,44 for useful materials properties
Fig. 2 Schematic view of the mussel byssus thread of M. edulis. The
enlargement depicts the pentablock copolymer containing b-sheet domains.
Reprinted with permission from (33), Copyright 1997 The American
Society for Biochemistry and Molecular Biology.
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higher molecular weight polymers are required. Protein engi-
neering is ideally suited for this purpose, especially because
production yields in bacteria are high (50–60 mg L21 culture)
when compared to other structural proteins.
Following up on earlier work by Urry, Conticello et al. have
used protein engineering techniques to synthesize elastin-based
block copolymers consisting of hydrophilic and hydrophobic
blocks.45 Protein engineering allows complete control of the
composition, sequence and length of the blocks. By careful
design, the critical micellization temperatures of these polymers
could be controlled, and the resulting materials are under
investigation as candidates for drug delivery. A second
demonstration of the versatility of protein engineering for the
preparation of elastin-based materials has been reported by the
same group. Hydrogels are important products in biomedical
applications. Ideally one wants to obtain control of mechanical
properties by regulating crosslink density and network forma-
tion. Using protein engineering, control over monomer compo-
sition, and therefore control over distribution of crosslinkable
moieties, is achieved easily. Conticello et al. synthesized
elastin-based materials containing one specific crosslinking
point (lysine) per 25 monomer units, allowing a high level of
control of crosslink density after reaction with bis(sulfosuccin-
imidyl) suberate.46
Another approach, which takes advantage of additional
possibilities of protein engineering was developed by Urry and
extended by Panitch et al., who reported new materials for
tissue-engineered vascular grafts.47,48 Oligopeptides were in-
troduced that contained either RGD (Urry) or REDV (Panitch)
domains, which are known to stimulate endothelial cell
binding.49 This approach yields matrix materials that exhibit
mechanical properties similar to those of the arterial wall and
that support adhesion of vascular endothelial cells. An exten-
sion of the polymer design was made by introduction of lysine
moieties, which allowed amine specific crosslinking of the
elastin matrix without disturbing the cell binding domains.50
The combination of structure and function in a well defined
manner as demonstrated by this example is almost impossible to
achieve by any method other than protein engineering.
Helical polypeptides
Leucine zipper peptides play key roles in the dimerization and
DNA-binding behavior of transcriptional regulatory proteins.
Related structures can be found within the keratins, the main
structural protein of hair and nails. The leucine zipper motif is
characterized by a consensus heptad repeat (abdcefg), in which
a and d are hydrophobic amino acids, (d most frequently
leucine) and the moieties at e and g are usually charged. In the
helical form of the zipper peptide, the residues at a and d are
arrayed along a single face of the helix. Exposure of this
hydrophobic face to the aqueous environment is reduced by
formation of a dimeric coiled-coil structure, while electrostatic
interactions between e and g residues modulate the stability of
the dimer. This feature has been exploited to prepare pH
dependent peptide-based hydrogels. Triblock copolymers were
constructed to comprise a central random coil (AG3PEG)x,
flanked by terminal leucine zipper domains (Fig. 3).51 These
domains consisted of six heptad repeats of which the choice of
a/d residues was based on the Jun oncogene product. A database
developed by Lupas et al.52 was used for the selection of the
residues occupying positions b, c and f. Nine of the 12 e and g
positions were occupied by Glu residues, which allowed
switching between the aggregated and dissociated states by
changes in pH or temperature. At low pH and low temperature
the materials formed elastic gels; increases in pH or in
temperature resulted in decreased viscosity and loss of hydrogel
properties.
Fig. 4 (a) Difference in molecular weight distribution of protein engineered poly L-glutamic acid (1) and a conventionally prepared sample (2). Reprinted
by permission from Nature (54), Copyright 1997 Macmillan Magazines Ltd.; (b) and (c) monodisperse poly-benzyl-L-glutamate shows a twisted smectic
liquid crystalline phase. Reprinted with permission from (55), Copyright 1998 American Chemical Society.
Fig. 3 (a) Amino acid sequence of the leucine zipper triblock copolymer; (b)
demonstration of reversible hydrogel formation. Reprinted with permission
from W. A. Petka, J. L. Harden, K. P. McGrath, D. Wirtz and D. A. Tirrell,
Science, 1998, 281, 389. Copyright 1998 American Association for the
Advancement of Science.
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Each of the examples examined thus far shows the need for
control over composition in order to engineer the properties of
the products. Molecular weight distribution is a second
parameter that is of importance in polymer chemistry, though its
influence on material properties is not always easy to anticipate.
One striking exception however, is the synthesis of the helical
polypeptide polybenzyl-L-glutamate (pBLG) (Fig. 4).
The polydisperse form, which can be prepared by NCA
polymerization, has been known for many years to exhibit
liquid crystalline behavior.53 Under most conditions, pBLG
forms a cholesteric phase, but certain solvents and temperatures
yield a nematic. Because of the broad distribution of molecular
weight a clear characterization has always been difficult. Using
protein engineering, monodisperse poly L-a-glutamic acid
could be synthesized, and posttranslationally modified to yield
pBLG. This monodisperse sample showed distinctly different
LC behavior. Instead of a nematic or cholesteric phase a twisted
smectic mesophase was obtained.54,55 The fact that all chains
were of the same length resulted in ordering in layers, which
was not possible in conventional polydisperse samples.
Increasing the scope of protein engineering
The foregoing examples illustrate some of the promise of
protein engineering as a tool for material synthesis. Especially
in cases where the information encoded in the primary amino
acid sequence governs higher ordered structures, and thereby
the ultimate material properties, protein engineering clearly
outperforms synthetic polymerization techniques.
One of the drawbacks of protein engineering in comparison
to the other techniques, however, is that the choice of building
blocks might be expected to be limited to the naturally occurring
amino acids. Many functional groups, which would be useful in
controlling properties or postmodification efforts, such as
alkenes, alkynes, or halogens, are not found in natural proteins.
The chemical versatility of amino acids containing unsaturated
side chains has recently been reviewed.56 Furthermore, in-
corporation of halides, especially fluoride, can have dramatic
effects on the physical properties of materials. Extension of the
set of amino acid building blocks to unnatural analogues that
can be utilized by the protein production mechanism of living
systems would therefore enlarge the possibilities of protein-
based materials.
This idea has intrigued several groups. A first approach is to
use stop (nonsense) codons or 4-base codons57 for the
introduction of unnatural amino acids. Suppressor tRNAs can
be found that overwrite these termination signals. If unnatural
amino acids can be coupled to these tRNA molecules, efficient
incorporation of analogues can be accomplished. This technique
has been applied in vitro for more than a decade.58 For this
approach to succeed in vivo it is necessary to introduce a
suppressor tRNA that is not recognized by the host enzymes that
couple amino acids to tRNAs (the aminoacyl-tRNA synthe-
tases).59,60 This can be achieved by using a suppressor tRNA
from an exogenous source such as yeast.61,62 Next, a synthetase
must be identified or developed to couple the unnatural amino
acid to the suppressor tRNA. This synthetase should also be
inactive toward other tRNAs. This method allows site-directed
insertion of the amino acid analogue at a single position, e.g. in
he active site of an enzyme. This method will have major impact
on the design of proteins that are used for functional purposes
Fig. 5 Schematic representation of the lamellar crystalline phase formed by
the peptide sequence ((AG)3FG)n, in which phenylalanine is replaced by p-
fluorophenylalanine. The green spots indicate amino acid side chains with
unnatural functionality, in this case fluorine, at the lamellar surface.
Fig. 6 An overview of the obtained results of Tirrell and coworkers with
respect to in vivo replacement of natural amino acids by their analogues.
Amino acids depicted in red are incorporated via standard auxotroph
methodologies. Mutant aminoacyl tRNA synthetases have to be applied to
be able to build in the blue amino acids. Analogues depicted in black are
incorporated after boosting synthetase activity.
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such as enzymes, since alteration of the overall physical
properties of the macromolecule generally cannot be achieved
through modification of a single site. An overview of this
technique has been published recently.63
An alternative method has been developed by Tirrell et al.,
based on much earlier work on substitution of natural amino
acids by their close structural analogues. This method uses so-
called bacterial auxotrophs, i.e. bacteria that have lost the ability
to produce one of the natural amino acids. Such bacterial strains
are dependent on the growth medium for obtaining this specific
amino acid. If an analogue is added to the medium, it can be
incorporated in place of the natural substrate, if it is recognized
by the corresponding aminoacyl-tRNA synthetase.
In order to reduce toxicity, the cells are grown first in a
medium containing all of the natural amino acids. When
sufficient cell density is reached, the cells are shifted to a new
medium which contains the analogue instead of the natural
amino acid.
This methodology has proven successful for a large number
of amino acids and derivatives thereof. Though the first
publications go back for several decades,64 only in recent years
has extensive research allowed replacement of phenylalanine,
proline, leucine, methionine, tyrosine and isoleucine with their
respective analogues.65–68
An interesting application of this method is the incorporation
of phenylalanine analogues into the b-sheet element
((AG)3FG)n. This sequence adopts a lamellar crystalline
structure, in which the phenylalanine residues are exposed to the
surface. Well-defined functional surfaces can now be created.
Replacement by p-fluorophenylalanine allowed the construc-
tion of fluorinated crystalline layers,65 and b-sheets containing
thiophene units from 3-thienylalanine66 can be regarded as
precursors for conducting polymers (Fig. 5).
Replacement of leucine by either trifluoroleucine or 2-amino-
4-methylhex-4-enoic acid in leucine zippers causes marked
effects on conformational stability. For example, in a leucine
zipper peptide characterized by a melting temperature of 48 °C,
the transition temperature was elevated to 61 °C by introduction
of trifluoroleucine, whereas the native structure was destabi-
lized by the introduction of the unsaturated analogue.69 This
simple example illustrates the extent to which incorporation of
amino acid analogues expands the possibilities for engineering
protein stability and protein–protein interactions.70
The most systematic study to date has concerned introduction
of methionine analogues. Homoallylglycine and homopro-
pargylglycine are especially effective as methionine surro-
gates.68,71 Although trans-crotylglycine is recognized by the
methionyl-tRNA synthetase, increasing the synthetase activity
of the host is required for protein production.72,73 The
possibility of using mutant synthetases has also been demon-
strated for p-bromophenylalanine74 and azatyrosine.75
With the methods described in this section, some of the
natural limitations of protein engineering are beginning to fade.
Tailor-made materials can now be designed with pre-defined
structures and properties (Fig. 6). Furthermore, protein engi-
neering is unique in combining structural with functional
elements, which can be either of natural origin, such as cell-
binding domains, or introduced by incorporation of unnatural
amino acids. The versatility and control of protein engineering
will make this an important synthetic approach to a new
generation of biomaterials.
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